Royal Gold (RGLD) Issues Stream Segment Sales Update for Q2
https://www.zacks.com/stock/news/2299300/royal-gold-rgld-issues-stream-segment-sales-update-for-q2?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2299300
Jul 10, 2024 - Royal Gold (RGLD) sells 52,600 gold equivalent ounces in the June-end quarter of 2024.
0
ArcelorMittal (MT)-Partners Begin Carbon Capture Trial in Ghent
https://www.zacks.com/stock/news/2298541/arcelormittal-mt-partners-begin-carbon-capture-trial-in-ghent?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2298541
Jul 09, 2024 - ArcelorMittal (MT), MHI and D-CRBN are trialing plasma technology at Gent to convert CO2 into carbon monoxide for steel and chemical production, aiming to reduce emissions.
0
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2297364/three-reasons-to-hold-bd-bdx-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2297364
Jul 05, 2024 - BD's (BDX) robust product portfolio raises optimism about the stock.
0
Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board
https://www.zacks.com/stock/news/2297381/masimo-masi-fights-politan-in-a-bid-to-retain-ceo-on-board?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2297381
Jul 05, 2024 - Will Masimo (MASI) lose its CEO in its fight against activist investor Politan Capital Management? The company's management and employees want Joe Kiani to continue as the CEO.
0
BASF (BASFY) Partners ENGIE for Sustainable Biomethane Supply
https://www.zacks.com/stock/news/2297292/basf-basfy-partners-engie-for-sustainable-biomethane-supply?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2297292
Jul 05, 2024 - BASF (BASFY) and ENGIE sign an agreement to supply biomethane to Ludwigshafen and Antwerp sites, supporting sustainable manufacturing and reducing carbon footprints.
0
Lucid Diagnostics (LUCD) Reports Positive ESOGUARD BE-1 Data
https://www.zacks.com/stock/news/2296986/lucid-diagnostics-lucd-reports-positive-esoguard-be-1-data?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2296986
Jul 04, 2024 - Lucid Diagnostic's (LUCD) ESOGUARD BE-1 study data shows high sensitivity and negative predictive value for the EsoGuard test, enhancing early detection of esophageal precancer in a screening population.
0
Barrick's (GOLD) Kibali Mine to Sustain Annual Gold Production
https://www.zacks.com/stock/news/2296873/barrick-s-gold-kibali-mine-to-sustain-annual-gold-production?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2296873
Jul 04, 2024 - Barrick's (GOLD) Kibali mine sustains high production and leads in renewable energy, fostering regional growth and biodiversity.
0
DOW Announces Launch of Bio-Based NORDEL REN EPDM at DKT 2024
https://www.zacks.com/stock/news/2296865/dow-announces-launch-of-bio-based-nordel-ren-epdm-at-dkt-2024?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2296865
Jul 04, 2024 - NORDEL REN EPDM is set to provide a lower-carbon product by using bio leftovers from other industries as raw material, thus helping DOW customers in the rubber business.
0
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
https://www.zacks.com/stock/news/2296843/here-s-why-you-should-add-davita-dva-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296843
Jul 04, 2024 - DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
0
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod
https://www.zacks.com/stock/news/2296717/icecure-medical-iccm-new-cryoablation-system-gets-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2296717
Jul 03, 2024 - IceCure Medical's (ICCM) XSense Cryoablation System receives FDA approval, marking a pivotal step in minimally-invasive tumor treatment across multiple medical fields
0